药物诱导的肝损伤由于阿瓦科班改善了mycophenolate mofetil:一个案例报告
Ryo Yamashita1, Yusuke Izumi1, Keisuke Takane1
1Department of General Medicine, The Jikei University School of Medicine, Daisan Hospital, Komae-si, Tokyo, Japan.
Medicine
|April 14, 2025
概括
氨酸莫菲蒂尔 (MMF) 在开始阿瓦科潘治疗后经历了肝损伤的抗中性细胞质抗体相关血管炎 (AAV) 患者中有效治疗药物诱导的肝损伤 (DILI).
科学领域:
- 类风湿病学 类风湿病学
- 肝病学 肝病学是一种肝病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 抗中性细胞质抗体相关性血管炎 (AAV) 是一种小血管死性血管炎.
- 葡萄糖皮质类药物是标准的AAV治疗方法,但具有长期风险.
- 阿瓦科潘是一种C5a受体对抗剂,可以提供另一种选择,但具有药物诱导性肝损伤 (DILI) 的风险.
研究的目的:
- 在患有AAV的患者中报告可能由阿瓦科班引起的DILI病例.
- 评估mycophenolate mofetil (MMF) 在治疗阿瓦科潘诱导的DILI中的疗效.
主要方法:
- 一名患有多炎 (一种AVA形式) 的颗粒瘤症患者在开始使用avacopan后出现严重的肝损伤.
- 标准治疗和停止阿瓦科班治疗未能解决肝损伤.
- 菌酸莫菲提尔 (MMF) 用于管理DILI.
主要成果:
- 患者的严重肝损伤在MMF开始后得到缓解.
- 这表明MMF可以作为阿瓦科班诱导的DILI的有效治疗方法.
结论:
- 氨酸莫菲蒂尔 (MMF) 在治疗与阿瓦科潘使用相关的药物诱导性肝损伤 (DILI) 中显示出有效性.
- 这一案例突出了在AAV患者中管理阿瓦科班诱导的肝毒性治疗的潜在治疗选择.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
105
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
105
Pulmonary Tuberculosis I
208
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
208
Drugs for Treatment of Ulcerative Colitis in IBD
106
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
106
Prevention of Further Absorption of Poison
749
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
749
Pharmacovigilance
748
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
748
Anticholinesterase Agents: Poisoning and Treatment
742
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
742


